Showing results (451-460 of 487) with videos related to
Sort By:
Pageof 49
Clinical and Experimental Nephrology|November 12, 2017
Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosisKengo Furuichi, Miho Shimizu, Yukio Yuzawa, et al.American Journal of Hypertension|January 29, 2019
Amplified Association Between Blood Pressure and Albuminuria in Overweight Patients With Biopsy-Proven Hypertensive NephrosclerosisKentaro Kohagura, Kengo Furuichi, Masako Kochi, et al.Cancer Medicine|May 1, 2021
Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohortKatsuhiro Ito, Takashi Kobayashi, Takahiro Kojima, et al.Journal of Diabetes Investigation|July 24, 2023
Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort studyMiho Shimizu, Kengo Furuichi, Tadashi Toyama, et al.Diabetes Care|March 6, 2019
Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort StudyMasayuki Yamanouchi, Kengo Furuichi, Junichi Hoshino, et al.Urologic Oncology|August 29, 2021
Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinomaRikiya Taoka, Takashi Kobayashi, Yu Hidaka, et al.Current Opinion in Urology|October 9, 2025
Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panelsBenjamin Pradere, Maarten Schuit, Félix Guerrero-Ramos, et al.Plos One|November 6, 2008
The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathwaysToshiyuki Fukada, Natacha Civic, Tatsuya Furuichi, et al.Journal of Geriatric Oncology|July 9, 2021
Efficacy and safety of pembrolizumab for older patients with chemoresistant urothelial carcinoma assessed using propensity score matchingNaotaka Nishiyama, Takashi Kobayashi, Shintaro Narita, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|September 21, 2021
Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumabMinoru Kato, Takashi Kobayashi, Yoshiyuki Matsui, et al.Pageof 49